Skip to Main Content
Back to News

Lobbying Update: $45,000 of HARMONY BIOSCIENCES lobbying was just disclosed

None

$45,000 of HARMONY BIOSCIENCES lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Producing meeting materials; Assisting in meetings to secure support at federal level and awareness to policymakers."

You can find more data on corporate lobbying on Quiver Quantitative.

HRMY Insider Trading Activity

HRMY insiders have traded $HRMY stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.

Here’s a breakdown of recent trading of $HRMY stock by insiders over the last 6 months:

  • JEFFREY DIERKS (CHIEF COMMERCIAL OFFICER) has made 0 purchases and 7 sales selling 63,039 shares for an estimated $2,354,077.
  • SANDIP KAPADIA (CHIEF FINANCIAL OFFICER) has made 0 purchases and 2 sales selling 26,775 shares for an estimated $1,072,144.
  • JEFFREY M. DAYNO (PRESIDENT, CEO) sold 19,293 shares for an estimated $774,245

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

HRMY Hedge Fund Activity

We have seen 133 institutional investors add shares of HRMY stock to their portfolio, and 101 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles